tiprankstipranks
Autolus Therapeutics Plc (AUTL)
NASDAQ:AUTL
US Market
AUTL
Autolus Therapeutics
RESEARCH TOOLSreports

Autolus Therapeutics (AUTL) Income Statement

925 Followers

Autolus Therapeutics Income Statement

Last quarter (Q4 2025), Autolus Therapeutics's total revenue was $24.25M, an increase of 83534.17% from the same quarter last year. In Q4, Autolus Therapeutics's net income was $-90.20M. See Autolus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 75.56M$ 10.12M$ 1.70M$ 6.19M$ 1.51M
Gross Profit
$ -21.03M$ -130.90M$ 1.70M$ 6.19M$ 1.51M
Operating Expenses
$ 260.41M$ 110.53M$ 181.40M$ 149.09M$ 141.88M
Depreciation and Amortization
$ 9.84M$ 7.72M$ 6.57M$ 7.42M$ 8.46M
EBITDA
$ -271.60M$ -233.07M$ -156.77M$ -132.24M$ -132.47M
Operating Income
$ -281.44M$ -241.43M$ -179.70M$ -142.89M$ -140.37M
Other Income/Expenses
$ -15.41M$ 22.29M$ -28.70M$ -5.67M$ -1.66M
Pretax Income
$ -296.85M$ -219.13M$ -208.40M$ -148.57M$ -142.04M
Net Income
$ -287.53M$ -220.66M$ -208.38M$ -148.84M$ -142.10M
Per Share Metrics
Basic EPS
$ -1.08$ -0.87$ -1.20$ -1.57$ -1.97
Diluted EPS
$ -1.08$ -0.87$ -1.20$ -1.57$ -1.97
Weighted Average Shares Outstanding
 266.14M 255.16M 173.94M 94.99M 72.08M
Weighted Average Shares Outstanding (Diluted)
 266.14M 255.16M 173.94M 94.99M 72.08M
Currency in USD

Autolus Therapeutics Earnings and Revenue History